Clinical trial Recruiting at 1 site Interventional Ages 20 to 90

Using brain stimulation to treat neuropathic pain

Official title: Combining Functional Magnetic Resonance Imaging and Transcranial Direct Current Stimulation to Investigate Pain-related Brain Networks in Patients With Neuropathic Pain

Run by National Taiwan University Hospital · NCT06237075 · Data updated 2026-11-12

This study is testing whether a brain stimulation technique can help people with neuropathic pain feel better by looking at how it affects their brain activity.

Quick facts

Study typeInterventional
Ages20 Years to 90 Years
SexAll
Enrollment150 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Taipei)
StatusRecruiting
StartedSeptember 11, 2023
Main results expectedSeptember 11, 2030
Study endsSeptember 11, 2030
Registry record updatedFebruary 1, 2024
Trial IDNCT06237075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 20 to 90 with confirmed neuropathic pain due to peripheral neuropathy.

Probably not a fit

Patients with severe systemic diseases, major neurological disorders, or significant mental health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the effects of transcranial direct current stimulation (tDCS) on neuropathic pain caused by peripheral neuropathy. The study employs a unique approach by combining tDCS with functional magnetic resonance imaging (fMRI) to observe the brain's response during stimulation. The primary targets for stimulation are the primary motor cortex and the dorsolateral prefrontal cortex. The goal is to enhance understanding of how tDCS can modulate pain-related brain networks and potentially improve treatment strategies for patients suffering from neuropathic pain.

Why it matters

Potential benefit: If successful, this approach could provide a novel non-invasive treatment option for patients with neuropathic pain who are unresponsive to conventional therapies.

How similar studies have gone: While the combination of tDCS and fMRI is a relatively novel approach, previous studies have shown promise in using tDCS for pain management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Age 20 or older and 90 or younger. 2. Ability to give informed consent 3. Neuropathic pain and/or nonpainful sensory symptoms resulted from I or II I. Peripheral neuropathy confirmed by clinical symptoms nerve conduction study, autonomic function test, quantitative sensory test, or skin biopsy.

II. Stroke involving somatosensory pathway confirmed by neuroimage 4. Agree not to take caffeine, alcohol, tea and drugs with significant nervous system effects for 48 hours before each study session.

Exclusion Criteria:

* 1\. Presence of sever systemic diseases, including severe ischemic heart disease or congestive heart failure (left ventricular ejection fraction \< 30%), severe lung diseases with dyspnea, severe generalized edema, and systemic infection 2. Presence of major neurological disorders, including brain tumor, head trauma and infection or inflammation of nervous system.

  3\. Presence of major depression or any major mental disorders 4. Presence of a cardiac pacemaker, brain stimulator, aneurysm clips or metal implants in the head, unless these devices are certified to be MRI-compatible 5. Pregnancy 6. Claustrophobia or any other contraindications to MRI 7. Inability to give informed consent.

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.